PML protein association with specific nucleolar structures differs in normal, tumor and senescent human cells (original) (raw)

Profile image of Zora NovakovaZora Novakova

2007, Journal of Structural Biology

visibility

description

15 pages

link

1 file

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact

Role and fate of PML nuclear bodies in response to interferon and viral infections

Mounira Chelbi-Alix

Oncogene, 2001

View PDFchevron_right

PML Nuclear Bodies and SATB1 Are Associated with HLA Class I Expression in EBV+ Hodgkin Lymphoma

Arjan Diepstra

PLoS ONE, 2013

View PDFchevron_right

Cytoplasmic localization of PML particles in laminopathies

Carlo Marcelis

Histochemistry and Cell Biology, 2013

View PDFchevron_right

PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation ofMMP2

Cheng-wen Wu

Cell Cycle, 2014

View PDFchevron_right

The PML isoform IV is a negative regulator of nuclear EGFR’s transcriptional activity in lung cancer

Cheng-wen Wu

Carcinogenesis, 2013

View PDFchevron_right

New strategies to direct therapeutic targeting of PML to treat cancers

Ygal Haupt

Frontiers in Molecular and Cellular Oncology, 2013

View PDFchevron_right

pMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL

Annemiek Boer

View PDFchevron_right

PML and COP1--two proteins with much in common

jose C reyes

2001

View PDFchevron_right

Pondering the Promyelocytic Leukemia Protein (PML) Puzzle: Possible Functions for PML Nuclear Bodies

Katherine Borden

Molecular and Cellular Biology, 2002

View PDFchevron_right

Identification of Piwil2-Like (PL2L) Proteins that Promote Tumorigenesis

Andrew Issekutz

PLoS ONE, 2010

View PDFchevron_right

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

MN1 and PTEN gene expression in acute myeloid leukemia

Maha A El-Taweel

Cancer Biomarkers, 2017

View PDFchevron_right

The tumor suppressor protein PML controls apoptosis induced by the HIV-1 envelope

Mehdi Bourouba

Cell Death and Differentiation, 2009

View PDFchevron_right

Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML

Paul Freemont

Journal of cell science, 1998

View PDFchevron_right

Finding a role for PML in APL pathogenesis: a critical assessment of potential PML activities

Stephen Strudwick, PhD, Katherine Borden

Leukemia, 2002

View PDFchevron_right

The PML gene encodes a phosphoprotein associated with the nuclear matrix

Zhao Mu

Blood, 1995

View PDFchevron_right

PML tumour suppression and beyond: Therapeutic implications

Ygal Haupt

FEBS Letters, 2014

View PDFchevron_right

Loss of the Tumor Suppressor PML in Human Cancers of Multiple Histologic Origins

Carlos Cordon-cardo

JNCI Journal of the National Cancer Institute, 2004

View PDFchevron_right

PML-containing nuclear bodies: Their spatial distribution in relation to other nuclear components

Hans van der Voort

Journal of Cellular Biochemistry, 1996

View PDFchevron_right

Matrix Metalloproteinase 3 Is Present in the Cell Nucleus and Is Involved in Apoptosis

Arnaud Monvoisin

American Journal of Pathology, 2006

View PDFchevron_right

Involvement of PML-I in reformation of PML nuclear bodies in acute promyelocytic leukemia cells by leptomycin B

LIAQAT HUSSAIN

Toxicology and Applied Pharmacology, 2019

View PDFchevron_right

Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin

W. Dirks

Leukemia, 2005

View PDFchevron_right

The Promyelocytic Leukemia Protein Protects p53 from Mdm2-mediated Inhibition and Degradation

Ronit v. Sionov

Journal of Biological Chemistry, 2003

View PDFchevron_right

PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity

Andrea Lunardi

Oncotarget, 2016

View PDFchevron_right

Programming cancer cells for high expression levels of Mcl1

Mai Nguyễn

EMBO reports, 2013

View PDFchevron_right

Contribution of the C-terminal Regions of Promyelocytic Leukemia Protein (PML) Isoforms II and V to PML Nuclear Body Formation

S. Monajembashi

Journal of Biological Chemistry, 2012

View PDFchevron_right

Surface residue mutations of the PML RING finger domain alter the formation of nuclear matrix-associated PML bodies

Estelle Duprez

Journal of Cell Science, 1997

View PDFchevron_right

Nuclear Matrix Proteins in Disparity of Prostate Cancer

Asim Abdel-Mageed

2010

View PDFchevron_right

PML protein isoforms and the RBCC/TRIM motif

Paul Freemont

Oncogene, 2001

View PDFchevron_right

PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase

Andre Megarbane

Journal of Cell Science, 2006

View PDFchevron_right

Ini1/hSNF5 is dispensable for retrovirus-induced cytoplasmic accumulation of PML and does not interfere with integration

Peter Sommer

FEBS Letters, 2004

View PDFchevron_right

The promyelocytic leukemia protein , PML , and its biological function

sadeq vallian

2005

View PDFchevron_right

PML protein expression in hematopoietic and acute promyelocytic leukemia cells

marcel koken

Blood, 1993

View PDFchevron_right

Functional Importance of PMCA Isoforms in Growth and Development of PC12 Cells

Christos Kargas

Annals of the New York Academy of Sciences, 2007

View PDFchevron_right

Identification of PML Oncogenic Domains (PODs) in Human Megakaryocytes

Elisabeth Cramer

Experimental Cell Research, 2001

View PDFchevron_right

Mutations of the PML tumor suppressor gene in APL

Taha Merghoub

Blood, in …, 2003

View PDFchevron_right

Structural BiologyStem CellsFluorescence MicroscopyConfocal MicroscopyStem CellTranscription FactorsStructuralCell lineHeLa cellsNeoplasmsCell Cycle regulationNucleolusHuman FibroblastsMesenchymal Stromal CellsProtein TransportBiochemistry and cell biologyHuman Mesenchymal Stem Cellsfibroblaststumor suppressor